(2006). A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA".
Chicago Style (17th ed.) CitationA Randomized, Double Blind, Cross-over, Placebo-controlled Clinical Trial to Assess the Effects of Candesartan on the Insulin Sensitivity on Non Diabetic, Non Hypertense Subjects with Dysglyce Mia and Abdominal Obesity. "ARAMIA". 2006.
MLA (8th ed.) CitationA Randomized, Double Blind, Cross-over, Placebo-controlled Clinical Trial to Assess the Effects of Candesartan on the Insulin Sensitivity on Non Diabetic, Non Hypertense Subjects with Dysglyce Mia and Abdominal Obesity. "ARAMIA". 2006.
Warning: These citations may not always be 100% accurate.